Startup Legal Checklist Before Signing a SAFE Agreement

What a SAFE is and why it dominates pre-seed

A SAFE (Simple Agreement for Future Equity) is a contract under which an investor gives a startup cash today in exchange for the right to receive shares at a future priced round. Instead of negotiating a valuation now, the parties agree on the terms that will set the price and share amount when the next real financing happens. SAFEs were popularized by Y Combinator and have become the default instrument for pre-seed and seed rounds because they are short, cheap to produce and fast to close.

For Israeli startups, SAFEs are commonly used with angel investors, accelerators and early institutional backers who are comfortable deferring valuation. The speed is real — a SAFE can be signed in days. But the speed hides a trade-off: the economic terms inside the SAFE, not the signature, determine how much of the company the founders keep after the next round.

SAFE vs convertible loan — the real difference

The main alternative to a SAFE is a convertible loan agreement (CLA). Both defer valuation, but they are structurally different. A CLA is debt: it has a principal amount, interest, a maturity date and, often, security. A SAFE is not debt — there is no repayment obligation, no interest and no maturity date.

The difference matters. With a CLA, if no priced round happens before maturity, the investor can demand repayment, creating real cash pressure on a company that may not have the funds. With a SAFE, there is no such repayment trigger, but the investor's money stays at risk until conversion. The choice affects investor rights, accounting treatment and how the next round converts. Founders should choose the instrument deliberately, not by default.

The valuation cap

The valuation cap sets the maximum effective valuation at which the SAFE converts. If the priced round is raised above the cap, the SAFE investors convert at the cap and receive more shares per dollar than new investors. If the round is below the cap, the cap does not bite and the discount usually applies instead.

The mistake founders make is accepting a cap to close the round quickly without modeling the dilution it produces. A low cap is generous to the investor and expensive to the founders. Before accepting a cap, model how many shares the SAFE investors receive at a range of plausible next-round valuations. The cap should reflect a realistic, slightly conservative next-round valuation — not a number chosen to make the round easy to close.

The discount

The discount gives the SAFE investor a percentage reduction off the priced-round share price — typically 20%. If the next round is priced at $10 per share and the discount is 20%, the SAFE investors convert at $8 per share. The discount rewards early investors for taking risk before a valuation is set.

The trap is granting both a low cap and a generous discount, so the investor is doubly protected and the founders are doubly diluted. Each protection reduces the founders' ownership at the next round. Understand which protection actually applies based on the next-round valuation, and avoid stacking more downside protection than the round requires.

Qualified financing — what triggers conversion

A SAFE converts into shares only when a qualified financing occurs — typically the next priced equity round above a minimum threshold set in the SAFE. The definition of qualified financing matters: it determines when conversion happens, which shares are issued, and whether the SAFE converts into the same preferred shares as the new investors or into a separate class.

Founders should read the definition carefully. What is the minimum amount that triggers it? Does it include only new-money priced equity, or also other instruments? A narrow definition can leave SAFEs unconverted longer than expected; a broad one can trigger conversion earlier. This is not boilerplate — it shapes the next round.

What happens if there is no next round

What happens if no priced round ever happens? This is the scenario founders rarely model. Most SAFEs include provisions for events other than a qualified financing: a change of control (exit), an IPO, or dissolution. Some include a liquidity-event conversion or a long-stop date after which the SAFE converts or is redeemed on agreed terms.

Without a priced round, the SAFE may convert at the cap on a liquidity event, or remain outstanding indefinitely. Founders should know exactly what the SAFE says about a world in which the next round does not arrive on the expected timeline — because rounds are frequently delayed, and a SAFE that assumes a quick priced round can become an awkward obligation years later.

What happens on an exit before a priced round

If the company is sold before a priced round, the SAFE typically either converts at the cap immediately before the sale or pays out a multiple of the invested amount. The choice is set in the SAFE and has a large economic effect: a cap-based conversion can give the investor a large share of exit proceeds; a fixed-multiple payout is more predictable.

Founders should understand which applies and model the proceeds split at a range of exit values. An exit before a priced round is not a remote edge case — many startups are acquired before their Series A — and the SAFE's exit terms decide how the proceeds are divided.

Most-favored-nation (MFN)

An MFN (most-favored-nation) clause entitles a SAFE investor to the benefit of any better terms the company grants to later SAFE investors before the priced round. The intent is to protect early investors from being diluted by later, more favorable SAFEs.

The risk is operational. An MFN means that every time the company signs a new SAFE on better terms, it must notify the MFN investors and offer them the same terms — creating administrative overhead and a compliance obligation that is easy to miss. Founders who sign an MFN without understanding the notification requirement can inadvertently breach the SAFE. MFN clauses are appropriate in some early, pre-cap rounds, but only when the founders understand the obligation they are taking on.

Pre-money vs post-money SAFE

SAFEs come in two flavors: pre-money and post-money. The difference is significant. A post-money SAFE calculates the investor's ownership against the cap table after all other conversions — including other SAFEs and the option pool — so the dilution to founders is explicit and predictable. A pre-money SAFE calculates against a pre-money valuation, and the interaction with other instruments is less transparent.

Y Combinator's current template is post-money, and most modern SAFEs are post-money. But founders must confirm which they are signing. Mixing pre- and post-money SAFEs in the same cap table creates confusion at the next round. Confirm the basis, and keep all SAFEs in a round on the same basis.

How a SAFE reshapes the cap table and dilutes founders

A SAFE does not appear on the cap table as issued shares, but it is fully-diluted dilution waiting to happen. When the priced round arrives, every outstanding SAFE converts and the founders' ownership shrinks. The cap, the discount, the number of SAFEs, and whether they are pre- or post-money together determine the dilution.

Model the cap table on a fully-diluted basis including all outstanding SAFEs before signing each new one. Founders who sign SAFEs one at a time often discover at the priced round that the combined dilution is far larger than they expected. The time to understand dilution is before signing — not at the next round's cap-table negotiation.

What the investor gets — and does not

Under a SAFE, the investor gets the right to future equity — not shares today, not debt, not governance rights, and usually no information rights until conversion. This is why SAFEs are fast: they defer the heavy terms (board seats, protective provisions, information rights) to the priced round.

What the investor does not get matters too. Until conversion, the SAFE investor typically has no voting rights, no board seat and no veto. Founders sometimes over-grant side letters (information rights, pro rata, advisory roles) on top of a SAFE that effectively give investors priced-round rights early. Each side letter is a negotiated term — review it as carefully as the SAFE itself.

Common mistakes founders make before signing

Several mistakes recur among founders signing SAFEs. Accepting the investor's first draft as standard. Setting the cap to close the round rather than to reflect realistic value. Stacking a low cap with a large discount. Signing multiple SAFEs with inconsistent terms. Granting pro rata or MFN rights to every small investor. Ignoring the pre- vs post-money basis. And treating the SAFE as a formality too small for legal review.

Each of these is avoidable. The common thread is treating the SAFE as a standard document rather than a negotiated contract whose terms decide future ownership. A short, informed review before signing prevents most of them.

When you must not sign without legal review

Do not sign a SAFE without legal review when the round is meaningful relative to your cap table, when the investor's draft deviates from the standard template, when side letters are attached, when the SAFE is pre-money mixed with post-money SAFEs, or when you have not modeled the dilution. A SAFE that looks short and simple can contain terms — on conversion, exit, MFN and side rights — that materially change ownership.

Documents to send your lawyer

To review a SAFE properly, send your lawyer: the SAFE draft (and any side letters), the current cap table, all outstanding SAFEs and convertible instruments, the intended next-round terms if known, and any investor correspondence that suggests non-standard terms. With these, counsel can model the dilution, flag non-standard clauses, check the qualified-financing definition, review MFN and pro rata rights, and confirm the pre- vs post-money basis.

A review takes far less time than unwinding a bad SAFE after signature — and far less than discovering the problem at the next round, when incoming investors and their counsel find it first.